JPRN-UMIN000024007已完成未知
Effectiveness and safety of ledipasvir and sofosbuvir for patients infected with HCV genotype 1 in clinical practices - Ledipasvir and sofosbuvir treatment for HCV genotype 1 patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Decompensated cirrhosis (Child B/C) (2)Autoimmune hepatitis or primary biliary cholangiris (3)eGFR<30 (4)Positivity for antibody to HIV
研究者
相似试验
尚未招募
不适用
Efficacy and safety of ledipasvir and sofosbuvir in patients with chronic hepatitis CPatients with chronic hepatitis C virus infectionJPRN-UMIN000018561Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology2,000
已完成
不适用
Efficacy and safety of ledipasvir/sofosubuvir/ribavirin combination therapy for failures to daculatasvir/asunaprevir combination therapy.Patients infected with HCV genotype 1, who failed to daculatasvir/asunaprevir comnination therapy.JPRN-UMIN000022418Toranomon Hospital, Department of Hepatology.20
招募中
不适用
Evaluation of the efficacy of sofosbuvir and ledipasvir for Japanese hepatitis C patients: a prospective study in real-life settings.chronic hepatitis CJPRN-UMIN000019468Toranomon Hospital100
已完成
不适用
Prospective study of Sofosbuvir and Ledipasvir for HCV genotype 1 infected Japanese patientsGenotype 1 infected chronic liver diseasesJPRN-UMIN000019400Osaka City University and affiliated hospitals400
已完成
不适用
Efficacy and safety of Ledipasvir/Sofosbuvir in chronic hepatitis C of Genotype1b with chronic kidney disease(eGFR30-60ml/min/1.73m2)Chronic hepatitis CJPRN-UMIN000027851ippon Medical School Chiba Hokusoh Hospital700